PEY3 RANIBIZUMAB (LUCENTIS®) IS A COST-EFFECTIVE TREATMENT OF AGE-RELATED MACULA DEGENERATION (AMD) IN THE GERMAN HEALTH CARE SYSTEM

✍ Scribed by AS Neubauer; El Back; T Kuehn; VS Thomas

• Book ID: 119596098
• Publisher: John Wiley and Sons
• Year: 2007
• Tongue: English
• Weight: 68 KB
• Volume: 10
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)65237-0